Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus - PubMed (original) (raw)
Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus
M Iwano et al. Kidney Int. 1996 Apr.
Free article
Abstract
Transforming growth factor-beta 1 (TGF-beta 1) is a primary determinant of the mesangial expansion observed in diabetic nephropathy. In this study, we quantitated the levels of intraglomerular TGF-beta 1 mRNA in patients with diabetes mellitus using a competitive polymerase chain reaction (PCR) method. Renal biopsy specimens were obtained from 29 patients with non-insulin-dependent diabetes mellitus. Total RNA was extracted from the glomeruli and reverse transcribed into cDNA with reverse transcriptase. To prepare samples containing identical amounts of beta-actin cDNA (8 pg), we performed competitive PCR by co-amplifying mutant templates of beta-actin with a unique EcoRI site. We also used this competitive PCR method to measure TGF-beta 1 cDNA by co-amplifying mutant templates of TGF-beta 1. We observed higher expression of TGF-beta 1 mRNA in glomeruli of patients with diabetic nephropathy as compared with normal glomeruli. Intraglomerular TGF-beta 1 mRNA was elevated, even in the early stage of diabetic nephropathy. Moreover, levels of intraglomerular TGF-beta 1 mRNA correlated with values of HbA1c. These data suggest that hyperglycemia induces intraglomerular TGF-beta 1 mRNA expression in vivo, and that TGF-beta 1 overproduction may be associated with the progression of diabetic nephropathy.
Comment in
- Evidence that TGF-beta should be a therapeutic target in diabetic nephropathy.
Border WA, Noble NA. Border WA, et al. Kidney Int. 1998 Oct;54(4):1390-1. doi: 10.1046/j.1523-1755.1998.00127.x. Kidney Int. 1998. PMID: 9773681 Review. No abstract available.
Similar articles
- Intraglomerular expression of transforming growth factor-beta 1 (TGF-beta 1) mRNA in patients with glomerulonephritis: quantitative analysis by competitive polymerase chain reaction.
Iwano M, Akai Y, Fujii Y, Dohi Y, Matsumura N, Dohi K. Iwano M, et al. Clin Exp Immunol. 1994 Aug;97(2):309-14. doi: 10.1111/j.1365-2249.1994.tb06086.x. Clin Exp Immunol. 1994. PMID: 8050182 Free PMC article. - Glomerular transforming growth factor-beta1 mRNA as a marker of glomerulosclerosis-application in renal biopsies.
Yang CW, Hsueh S, Wu MS, Lai PC, Huang JY, Wu CH, Hu SA, Chen JF, Huang CC. Yang CW, et al. Nephron. 1997;77(3):290-7. doi: 10.1159/000190290. Nephron. 1997. PMID: 9375822 - Expression of transforming growth factor-beta 1 during diabetic renal hypertrophy.
Shankland SJ, Scholey JW, Ly H, Thai K. Shankland SJ, et al. Kidney Int. 1994 Aug;46(2):430-42. doi: 10.1038/ki.1994.291. Kidney Int. 1994. PMID: 7967355 - Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes.
Park IS, Kiyomoto H, Abboud SL, Abboud HE. Park IS, et al. Diabetes. 1997 Mar;46(3):473-80. doi: 10.2337/diab.46.3.473. Diabetes. 1997. PMID: 9032105 - Gremlins, glomeruli and diabetic nephropathy.
Lappin DW, Hensey C, McMahon R, Godson C, Brady HR. Lappin DW, et al. Curr Opin Nephrol Hypertens. 2000 Sep;9(5):469-72. doi: 10.1097/00041552-200009000-00002. Curr Opin Nephrol Hypertens. 2000. PMID: 10990363 Review.
Cited by
- Interplay Between TGF-β Signaling and MicroRNA in Diabetic Cardiomyopathy.
Qin J, Tan Y, Han Y, Yu L, Liu S, Zhao S, Wan H, Qu S. Qin J, et al. Cardiovasc Drugs Ther. 2023 Dec 20. doi: 10.1007/s10557-023-07532-2. Online ahead of print. Cardiovasc Drugs Ther. 2023. PMID: 38117422 Review. - Transforming Growth Factorβ1 Overexpression Is Associated with Insulin Resistance and Rapidly Progressive Kidney Fibrosis under Diabetic Conditions.
D'Alessandro VF, Takeshita A, Yasuma T, Toda M, D'Alessandro-Gabazza CN, Okano Y, Tharavecharak S, Inoue C, Nishihama K, Fujimoto H, Kobayashi T, Yano Y, Gabazza EC. D'Alessandro VF, et al. Int J Mol Sci. 2022 Nov 17;23(22):14265. doi: 10.3390/ijms232214265. Int J Mol Sci. 2022. PMID: 36430743 Free PMC article. - Vitamin D protects glomerular mesangial cells from high glucose-induced injury by repressing JAK/STAT signaling.
Yang Y, Lei Y, Liang Y, Fu S, Yang C, Liu K, Chen Y. Yang Y, et al. Int Urol Nephrol. 2021 Jun;53(6):1247-1254. doi: 10.1007/s11255-020-02728-z. Epub 2021 May 3. Int Urol Nephrol. 2021. PMID: 33942213 Free PMC article. - Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors.
DeFronzo RA, Reeves WB, Awad AS. DeFronzo RA, et al. Nat Rev Nephrol. 2021 May;17(5):319-334. doi: 10.1038/s41581-021-00393-8. Epub 2021 Feb 5. Nat Rev Nephrol. 2021. PMID: 33547417 Review. - Research Progress on the Pathological Mechanisms of Podocytes in Diabetic Nephropathy.
Zhang L, Wen Z, Han L, Zheng Y, Wei Y, Wang X, Wang Q, Fang X, Zhao L, Tong X. Zhang L, et al. J Diabetes Res. 2020 Jul 8;2020:7504798. doi: 10.1155/2020/7504798. eCollection 2020. J Diabetes Res. 2020. PMID: 32695831 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical